Toxic Megacolon Questions & Answers

1. Strong SA. Management of acute colitis and toxic megacolon. Clin Colon Rectal Surg. 2010 Dec. 23(4):274-84. [Medline]. [Full Text].

2. Marshak RH, Lester LJ. Megacolon a complication of ulcerative colitis. Gastroenterology. 1950 Dec. 16(4):768-72. [Medline].

3. Jalan KN, Sircus W, Card WI, et al. An experience of ulcerative colitis. I. Toxic dilation in 55 cases. Gastroenterology. 1969 Jul. 57(1):68-82. [Medline].

4. Moulin V, Dellon P, Laurent O, Aubry S, Lubrano J, Delabrousse E. Toxic megacolon in patients with severe acute colitis: computed tomographic features. Clin Imaging. 2011 Nov-Dec. 35(6):431-6. [Medline].

5. Autenrieth DM, Baumgart DC. Toxic megacolon. Inflamm Bowel Dis. 2012 Mar. 18(3):584-91. [Medline].

6. Khasanov R, Schaible T, Wessel LM, Hagl CI. The surgical treatment of toxic megacolon in Hirschsprung disease. Pediatr Emerg Care. 2016 Nov. 32(11):785-8. [Medline].

7. Sheth SG, LaMont JT. Toxic megacolon. Lancet. 1998 Feb 14. 351(9101):509-13. [Medline].

8. Mourelle M, Casellas F, Guarner F, et al. Induction of nitric oxide synthase in colonic smooth muscle from patients with toxic megacolon. Gastroenterology. 1995 Nov. 109(5):1497-502. [Medline]. [Full Text].

9. Mourelle M, Vilaseca J, Guarner F, Salas A, Malagelada JR. Toxic dilatation of colon in a rat model of colitis is linked to an inducible form of nitric oxide synthase. Am J Physiol. 1996 Mar. 270(3 pt 1):G425-30. [Medline].

10. Guslandi M. Nitric oxide and inflammatory bowel diseases. Eur J Clin Invest. 1998 Nov. 28(11):904-7. [Medline].

11. Roy MA. Inflammatory bowel disease. Surg Clin North Am. 1997 Dec. 77(6):1419-31. [Medline].

12. Bartlett JG, Perl TM. The new Clostridium difficile--what does it mean?. N Engl J Med. 2005 Dec 8. 353(23):2503-5. [Medline].

13. Arumilli BR, Koneru P, Fayyaz I. Toxic megacolon from hypervirulent Clostridium difficile infection (ribotype 027) following elective total knee replacement: an emerging challenge in modern health care. BMJ Case Rep. 2010. 2010:[Medline]. [Full Text].

14. Sayedy L, Kothari D, Richards RJ. Toxic megacolon associated Clostridium difficile colitis. World J Gastrointest Endosc. 2010 Aug 16. 2(8):293-7. [Medline]. [Full Text].

15. Sidebotham EL, Sepkowitz K, Price AP, Steinherz PG, La Quaglia MP, Kayton ML. Eradication of cryptosporidium from a defunctionalized colon limb by refeeding stoma effluent. J Pediatr Surg. 2010 Jan. 45(1):E33-6. [Medline].

16. Shimada Y, Iiai T, Okamoto H, et al. Toxic megacolon associated with cytomegalovirus infection in ulcerative colitis. J Gastroenterol. 2003. 38(11):1107-8. [Medline].

17. Hung CW, Wu WF, Wu CL. Rotavirus gastroenteritis complicated with toxic megacolon. Acta Paediatr. 2009 Nov. 98(11):1850-2. [Medline].

18. Mohite U, Kell J, Haj MA, et al. Invasive aspergillosis localised to the colon presenting as toxic megacolon. Eur J Haematol. 2007 Mar. 78(3):270-3. [Medline].

19. Khoury-Hanold W, Yordy B, Kong P, et al. Viral spread to enteric neurons links genital HSV-1 infection to toxic megacolon and lethality. Cell Host Microbe. 2016 Jun 8. 19(6):788-99. [Medline].

20. Wodzinski MA, Snowden JA, Reilly JT. Toxic megacolon complicating chemotherapy for acute myeloid leukaemia. Postgrad Med J. 1994 Dec. 70(830):921-3. [Medline].

21. Hayes-Lattin BM, Curtin PT, Fleming WH, et al. Toxic megacolon: a life-threatening complication of high-dose therapy and autologous stem cell transplantation among patients with AL amyloidosis. Bone Marrow Transplant. 2002 Sep. 30(5):279-85. [Medline].

22. Fitzgerald SC, Conlon S, Leen E, Walsh TN. Collagenous colitis as a possible cause of toxic megacolon. Ir J Med Sci. 2009 Mar. 178(1):115-7. [Medline].

23. Bains S, Lloyd GM, Sutton CD, West K, Miller AS. A case of toxic megacolon in a patient with collagenous colitis. Tech Coloproctol. 2009 Jun. 13(2):165-6. [Medline].

24. Umehara Y, Kudo M, Kawasaki M. Endoscopic findings of intestinal Behçet's disease complicated with toxic megacolon. Endoscopy. 2010. 42 Suppl 2:E173-4. [Medline].

25. Adorian C, Khoury G, Tawil A, Sharara A. Behçet's disease complicated by toxic megacolon. Dig Dis Sci. 2003 Dec. 48(12):2366-8. [Medline].

26. Tschudin-Sutter S, Tamma PD, Naegeli AN, et al. Distinguishing community-associated from hospital-associated Clostridium difficile infections in children: implications for public health surveillance. Clin Infect Dis. 2013 Dec. 57(12):1665-72. [Medline].

27. Greenstein AJ, Sachar DB, Gibas A, et al. Outcome of toxic dilatation in ulcerative and Crohn's colitis. J Clin Gastroenterol. 1985 Apr. 7(2):137-43. [Medline].

28. Grant CS, Dozois RR. Toxic megacolon: ultimate fate of patients after successful medical management. Am J Surg. 1984 Jan. 147(1):106-10. [Medline].

29. Maconi G, Sampietro GM, Ardizzone S, et al. Ultrasonographic detection of toxic megacolon in inflammatory bowel diseases. Dig Dis Sci. 2004 Jan. 49(1):138-42. [Medline].

30. Panos MZ, Wood MJ, Asquith P. Toxic megacolon: the knee-elbow position relieves bowel distension. Gut. 1993 Dec. 34(12):1726-7. [Medline]. [Full Text].

31. Present DH, Wolfson D, Gelernt IM, et al. Medical decompression of toxic megacolon by "rolling." A new technique of decompression with favorable long-term follow-up. J Clin Gastroenterol. 1988 Oct. 10(5):485-90. [Medline].

32. Actis GC, Ottobrelli A, Pera A, et al. Continuously infused cyclosporine at low dose is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without the need for high-dose steroids. J Clin Gastroenterol. 1993 Jul. 17(1):10-3. [Medline].

33. Sriram PV, Reddy KS, Rao GV, Santosh D, Reddy DN. Infliximab in the treatment of ulcerative colitis with toxic megacolon. Indian J Gastroenterol. 2004 Jan-Feb. 23(1):22-3. [Medline].

34. van Geenen EJ, Sachar DB. Infliximab in Crohn's disease-associated toxic megacolon. J Clin Gastroenterol. 2012 Apr. 46(4):321-3. [Medline].

35. Sawada K, Egashira A, Ohnishi K, et al. Leukocytapheresis (LCAP) for management of fulminant ulcerative colitis with toxic megacolon. Dig Dis Sci. 2005 Apr. 50(4):767-73. [Medline].

36. Kuroki K, Masuda A, Uehara H, Kuroki A. A new treatment for toxic megacolon. Lancet. 1998 Sep 5. 352(9130):782. [Medline].

37. Shetler K, Nieuwenhuis R, Wren SM, Triadafilopoulos G. Decompressive colonoscopy with intracolonic vancomycin administration for the treatment of severe pseudomembranous colitis. Surg Endosc. 2001 Jul. 15(7):653-9. [Medline].

38. Pascu M, Muller AR, Wiedenmann B, Dignass AU. Rescue therapy with tacrolimus in a patient with toxic megacolon. Int J Colorectal Dis. 2003 May. 18(3):271-5. [Medline].

39. Shah PJ, Vakil N, Kabakov A. Role of intravenous immune globulin in streptococcal toxic shock syndrome and Clostridium difficile infection. Am J Health Syst Pharm. 2015 Jun 15. 72(12):1013-9. [Medline].

40. Tapani MJ, Olavi KH. Surgical management of toxic megacolon. Hepatogastroenterology. 2014 May. 61(131):638-41. [Medline].

41. Heppell J, Farkouh E, Dube S, et al. Toxic megacolon. An analysis of 70 cases. Dis Colon Rectum. 1986 Dec. 29(12):789-92. [Medline].

42. Lee EC, Truelove SC. Proctocolectomy for ulcerative colitis. World J Surg. 1980. 4(2):195-201. [Medline].

43. Leppkes M, Ganslmayer M, Strauss R, Neurath MF. [Toxic megacolon] [German]. Med Klin Intensivmed Notfmed. 2015 Oct. 110(7):500-5. [Medline].

44. Moura FA, de Andrade KQ, Dos Santos JC, Araujo OR, Goulart MO. Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?. Redox Biol. 2015 Dec. 6:617-39. [Medline].

45. Neumann H, Neurath MF, Atreya R. Endoscopic therapy in inflammatory bowel diseases. Viszeralmedizin. 2015 Aug. 31(4):280-6. [Medline]. [Full Text].

46. Siow VS, Bhatt R, Mollen KP. Management of acute severe ulcerative colitis in children. Semin Pediatr Surg. 2017 Dec. 26(6):367-72. [Medline].

47. McConnie R, Kastl A. Clostridium difficile, colitis, and colonoscopy: pediatric perspective. Curr Gastroenterol Rep. 2017 Aug. 19(8):34. [Medline].

Brian Lin New York College of Osteopathic Medicine

Brian Lin is a member of the following medical societies: American College of Osteopathic Family Physicians, American College of Osteopathic Internists, American College of Physicians, American Medical Student Association/Foundation, Asian Pacific American Medical Student Association, Student Osteopathic Medical Association

Disclosure: Nothing to disclose.

George Y Wu, MD, PhD Professor, Department of Medicine, Director, Hepatology Section, Herman Lopata Chair in Hepatitis Research, University of Connecticut School of Medicine

George Y Wu, MD, PhD is a member of the following medical societies: American Association for the Study of Liver Diseases, American Gastroenterological Association, American Medical Association, American Society for Clinical Investigation, Association of American Physicians

Disclosure: Nothing to disclose.

Burt Cagir, MD, FACS Clinical Professor of Surgery, Geisinger Commonwealth School of Medicine; Director, General Surgery Residency Program, Guthrie Robert Packer Hospital; Attending Surgeon, Guthrie Robert Packer Hospital and Corning Hospital

Burt Cagir, MD, FACS is a member of the following medical societies: American College of Surgeons, Association of Program Directors in Surgery, Society for Surgery of the Alimentary Tract

Disclosure: Nothing to disclose.

Clifford Y Ko, MD, MS Professor, Department of Surgery, University of California, Los Angeles, David Geffen School of Medicine

Clifford Y Ko, MD, MS is a member of the following medical societies: American College of Surgeons, American Medical Association, American Society of Colon and Rectal Surgeons, Association for Academic Surgery, California Medical Association, New York Academy of Sciences

Disclosure: Nothing to disclose.

Lisa M Rossi, MD Fellow, Department of Gastroenterology-Hepatology, University of Connecticut School of Medicine

Disclosure: Nothing to disclose.

Deepika Devuni, MD Assistant Professor of Gastroenterology, University of Massachusetts Medical School

Deepika Devuni, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American Association of Physicians of Indian Origin, American College of Gastroenterology, American Gastroenterological Association, American Society of Transplantation

Disclosure: SIte PI for: Sequana Medical .

Douglas M Heuman, MD, FACP, FACG, AGAF Chief of GI, Hepatology, and Nutrition at North Shore University Hospital/Long Island Jewish Medical Center; Professor, Department of Medicine, Hofstra North Shore-LIJ School of Medicine

Douglas M Heuman, MD, FACP, FACG, AGAF is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Physicians, and American Gastroenterological Association

Disclosure: Novartis Grant/research funds Other; Bayer Grant/research funds Other; Otsuka Grant/research funds None; Bristol Myers Squibb Grant/research funds Other; Scynexis None None; Salix Grant/research funds Other; MannKind Other

Terence David Lewis, MBBS, FRACP, FRCPC, FACP Program Director, Internal Medicine Residency, & Assistant Chairman, Associate Professor, Department of Internal Medicine, Division of Gastroenterology, Loma Linda University Medical Center

Terence David Lewis, MBBS, FRACP, FRCPC, FACP is a member of the following medical societies: American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, American Medical Association, California Medical Association, Royal College of Physicians and Surgeons of Canada, and Sigma Xi

Disclosure: Nothing to disclose.

Jerome H Liu, MD Staff Physician, Department of Surgery, University of California at Los Angeles Medical Center

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

• Print this section
• Print the entire contents of
• Print the entire contents of article